Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-18 Purchase |
2022-11-22 08:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
10,000 | $1.8945 | $18,945 | 75,374 (Direct) |
View |
| 2022-09-08 Purchase |
2022-09-12 09:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
10,308 | $2.8 | $28,862 | 65,374 (Direct) |
View |
| 2022-09-07 Purchase |
2022-09-09 09:00 am |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer |
150 | $2.62 | $393 | 150 (Direct) |
View |
| 2022-09-06 Purchase |
2022-09-08 09:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
9,692 | $2.5558 | $24,771 | 55,066 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 08:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
19,727 | $2.63 | $51,882 | 45,374 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 5:08 pm |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
20,000 | $5.0021 | $100,043 | 1,368,356 (Indirect) |
View |
| 2021-11-18 Purchase |
2021-11-19 09:16 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
11,187 | $5.82 | $65,108 | 25,647 (Direct) |
View |
| 2021-09-14 Purchase |
2021-09-16 6:22 pm |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
12,000 | $7 | $84,000 | 14,460 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-30 Option Award |
2022-10-03 4:31 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | Karah Hila Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:30 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director |
81,000 | $0 | 81,000 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:30 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:30 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | O'CALLAGHAN BRIAN Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:30 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:30 pm |
N/A 2032-09-30 |
Indaptus Therapeutics Inc. | INDP | Hayes William B Director |
13,750 | $0 | 13,750 (Direct) |
View |
Ownership |
2022-07-07 4:36 pm |
N/A N/A |
Indaptus Therapeutics Inc. | INDP | Anderson Glen R. 10% Owner |
0 | $0 | 1,087,048 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-28 4:30 pm |
N/A 2032-02-25 |
Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:08 pm |
N/A 2032-02-01 |
Indaptus Therapeutics Inc. | INDP | Litchev Boyan Vesselinov Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:31 pm |
N/A 2032-01-26 |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
43,350 | $0 | 43,350 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:30 pm |
N/A 2032-01-26 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 4:30 pm |
N/A 2032-01-26 |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer |
45,850 | $0 | 45,850 (Direct) |
View |
| 2021-12-01 Option Award |
2021-12-08 9:58 pm |
N/A 2031-12-01 |
Indaptus Therapeutics Inc. | INDP | Gilbert Mark John Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | O'CALLAGHAN BRIAN Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2026-08-04 |
Indaptus Therapeutics Inc. | INDP | Sassi Nir Chief Financial Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
375,000 | $0 | 375,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Lee Hoonmo Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Linscott Walt Addison Chief Business Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Hayes William B Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Newman Michael James CSO and Director Director 10% Owner |
290,000 | $0 | 290,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Pomerantz Roger Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | MADDALUNA ANTHONY J Director |
13,750 | $0 | 13,750 (Direct) |
View |
| 2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Karah Hila Director |
13,750 | $0 | 13,750 (Direct) |
View |
Ownership |
2021-08-06 4:35 pm |
N/A 2028-11-25 |
Indaptus Therapeutics Inc. | INDP | O'CALLAGHAN BRIAN Director |
0 | $0 | 20,926 (Direct) |
View |
Ownership |
2021-08-06 4:35 pm |
N/A N/A |
Indaptus Therapeutics Inc. | INDP | Lee Hoonmo Director 10% Owner |
0 | $0 | 694,522 (Indirect) |
View |
Ownership |
2021-08-06 4:35 pm |
N/A N/A |
Indaptus Therapeutics Inc. | INDP | Newman Michael James Chief Scientific Officer 10% Owner |
0 | $0 | 1,388,356 (Indirect) |
View |
Ownership |
2021-08-02 4:46 pm |
N/A 2025-06-28 |
Intec Parent Inc. | NTEC | Hayes William B Director |
0 | $0 | 1,000 (Direct) |
View |
Ownership |
2021-08-02 4:46 pm |
N/A 2026-05-22 |
Intec Parent Inc. | NTEC | Karah Hila Director |
0 | $0 | 1,281 (Direct) |
View |
Ownership |
2021-08-02 4:45 pm |
N/A 2027-10-23 |
Intec Parent Inc. | NTEC | Linscott Walt Addison Chief Business Officer |
0 | $0 | 8,500 (Direct) |
View |
Ownership |
2021-08-02 4:45 pm |
N/A N/A |
Intec Parent Inc. | NTEC | Meckler Jeffrey A Chief Executive Officer |
0 | $0 | 16,086 (Direct) |
View |